Explorez tous les épisodes du podcast Decera Clinical Education Infectious Disease Podcast

Just as pneumonia isn’t “just a cold,” the pneumococcal vaccine does much more than just protect yourself or your child against pneumonia. Listen in and learn from experts Robert H. Hopkins, Jr., MD, and Brenda L. Tesini, MD, how to discuss the full benefits of pneumococcal vaccine. 

Topics covered include:

• Burden of pneumococcal disease among pediatric and older adult populations in the United States
• Risk factors for severe pneumococcal disease
• Which pneumococcal vaccines to use for certain populations and why
• How pneumococcal vaccination protects from long-term sequelae and potential community benefits of vaccination

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Robert H. Hopkins, Jr., MD
Professor of Internal Medicine and Pediatrics
Division of General Internal Medicine
University of Arkansas for Medical Sciences, School of Medicine
Little Rock, Arkansas

Brenda L. Tesini, MD
Associate Professor of Medicine, Pediatrics, and Community Health
Division of Infectious Diseases
University of Rochester Medical Center
Rochester, New York

Link to program page: 
https://bit.ly/3SuymiN

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In the final episode of a 3-part series, featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPNP-PC, CNE explore how to use “prebunking” strategies to inoculate patients and caregivers against vaccine misinformation and disinformation, as well as proven strategies to provide effective vaccine recommendations. Visit the program page to view the full on-demand webcast and download the accompanying slides.

Topics covered include: 

• “Prebunking” Tactics
• Presumptive Recommendations
• Motivational Interviewing Principles 
• Responding to Arguments Against Immunization 

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP
Clinical Assistant Professor 
Stony Brook University School of Nursing 
Nurse Consultant 
Immunize.org 
Owner/NP Pediatric Nurse Practitioner House Calls
Stony Brook, New York

Patricia Stinchfield, MS, RN, PNP
Independent Consultant
Victoria, Minnesota
(Retired) Senior Director, Infection Prevention & Control, Infectious Disease
Children’s Minnesota
Immediate Past President, National Foundation for Infectious Diseases
Minneapolis, Minnesota

Jennifer M. Walsh, DNP, CPNP-PC, CNE
Certified Pediatric Nurse Practitioner – Primary Care
Assistant Professor
School of Nursing
George Washington University
Washington, DC

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In the second episode of a 3-part series featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPNP-PC, CNE explore effective strategies to counter common myths and misconceptions about vaccines, including actionable methods to champion the benefits and safety of pediatric vaccines. Visit the program page to view the full on-demand webcast and download the accompanying slides.

Topics covered include: 

• Debunking the Link Between Vaccines and Autism 
• Reemergence of Previously Eliminated Diseases
• Building Trust With Parents and Caregivers
• Who and How to Debunk Vaccine Misinformation

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP
Clinical Assistant Professor 
Stony Brook University School of Nursing 
Nurse Consultant 
Immunize.org 
Owner/NP Pediatric Nurse Practitioner House Calls
Stony Brook, New York

Patricia Stinchfield, MS, RN, PNP
Independent Consultant
Victoria, Minnesota
(Retired) Senior Director, Infection Prevention & Control, Infectious Disease
Children’s Minnesota
Immediate Past President, National Foundation for Infectious Diseases
Minneapolis, Minnesota

Jennifer M. Walsh, DNP, CPNP-PC, CNE
Certified Pediatric Nurse Practitioner – Primary Care
Assistant Professor
School of Nursing
George Washington University
Washington, DC

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Pneumococcal vaccine recommendations are constantly evolving to respond to shifting patterns of infections, which is a good thing. However, the nuances can be complicated to explain to patients. Listen in to learn how experts Richard Colgan, MD and Brenda L. Tesini, MD, discuss changing pneumococcal vaccine recommendations. Topics covered include: 

• Epidemiologic changes: S. pneumoniae over time
• Burden on patients and the health system
• Adjustments to pneumococcal vaccine recommendations
• Considerations for vaccine selection

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Richard Colgan, MD
Professor Emeritus
Department of Family and Community Medicine
University of Maryland School of Medicine
Medical Alumni Association
Carolyn Frenkil Selvin Passen History of Medicine
Scholar in Residence
Baltimore, Maryland

Brenda L. Tesini, MD
Associate Professor of Medicine, Pediatrics, and Community Health
Division of Infectious Diseases
University of Rochester Medical Center
Rochester, New York

Link to program page: 
https://bit.ly/3RNHkHr

Links mentioned in this episode: 
PneumoRecs VaxAdvisor App for Vaccine Providers | Pneumococcal | CDC

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, and Su Wang, MD, MPH, FACP, discuss how to incorporate knowledge of hepatitis A and B risk factors and disease burden into patient counseling to enhance uptake of hepatitis A and B vaccines. Topics covered include:

• The burden of hepatitis A and B in the United States
• Risk factors for infection
• Current evidence-based recommendations for hepatitis A and B vaccination. 

Follow along with the slides here, and get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Stanford, California

Jewel Mullen, MD, MPH, MPA, FACP
Associate Professor of Population Health and Internal Medicine
University of Texas at Austin Dell Medical School
Austin, Texas

Su Wang, MD, MPH, FACP
Medical Director, Center for Asian Health & Viral Hepatitis Programs
Cooperman Barnabas Medical Center/RWJBarnabas-Rutgers Medical Group
Assistant Clinical Professor, Rutgers New Jersey Medical Group
Florham Park, New Jersey

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how the recent approvals fit in the treatment landscape of 2-drug, single-tablet regimens. Stream on the go or follow along with our expert-curated slides. 

Topics covered include: 

• Guideline recommendations on ART switch in the setting of virologic suppression
• Phase III clinical trial data supporting ART switch
• Individual considerations for ART switch

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom of Great Britain and Northern Ireland
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Peter J. Ruane, MD
President
Ruane Clinical Research
Los Angeles, California

Link to program page: 
https://bit.ly/3PkPoP4

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-experienced people with challenges using currently available regimens, high pill burdens, and reduced adherence. Listen on the go or follow along with our expert-curated slides. Topics covered include:

• Current Options for Simplifying ART
• DHHS and EACS Recommendations for 2-Drug Regimens
• The Latest Results of the ARTISTRY-1 and -2 Trials
• Future Directions for HIV Therapy

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Faculty of Medicine and Dentistry
Queen Mary University of London 
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Jihad Slim, MD
Assistant Professor of Medicine
New York Medical College
Valhalla, New York
Chief of Infectious Disease
Saint Michael’s Medical Center
Newark, New Jersey

Link to program page: 
https://bit.ly/4u31NGv

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as Bright Ansah, patient advocate, describes his experience with being diagnosed with chronic hepatitis B as a recent immigrant to the United States and the unique barriers to treatment faced by the African immigrant community. Through his story, learn how healthcare professionals can reduce these barriers for this key population.

Topics covered include:

• Key barriers to care for African immigrant patients
• Myths and misconceptions about HBV in the African immigrant community

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Link to program page: 
https://bit.ly/4uz25Vc

Presenter:

Bright Ansah 
HBV Patient Advocate
Frederick, Maryland

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as experts Charlotte-Paige Rolle, MD, MPH, and Paul E. Sax, MD, discuss the most recent studies on emerging treatment options for treatment-experienced people living with HIV. Topics covered include:

• ARTISTRY-1 and -2 data on the investigational combination of BIC/LEN
• Data on investigational DOR/ISL, specifically in people with multidrug-resistant HIV
• bNAb combinations 
• SUPLA trial of LA CAB plus RPV in people with viremia who have challenges with their oral regimens

To download the accompanying slides, please visit the program page: 
https://bit.ly/4cHPI1Y

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Charlotte-Paige Rolle, MD, MPH
Director of Research Operations
Orlando Immunology Center
Adjunct Assistant Professor of Global Health
Emory University Rollins School of Public Health
Atlanta, Georgia

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For US veterans, support for continued engagement in hepatitis B (HBV) care has been lacking. Listen in as Richelle M. Gaiter, DMSc, MPAS, Med, shares her experiences with HBV care as an Air Force veteran and what can be done to improve HBV care for veterans and civilians alike. Topics include: 

• Key barriers to HBV care for US veterans
• What has improved in the last decade
• Strategies for improved engagement in care

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify.

Link to program page:
https://bit.ly/4vAqSJT

Presenter:

Richelle M. Gaiter, CMSGT Retired USAFR, DMSc, MPAS, Med
Family Medicine, Prevention, Patient Education
Crescent City, California

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Unwanted body habitus changes among people living with HIV receiving antiretroviral therapy (ART) can negatively affect physical and mental health and may even affect ART adherence. Listen to learn from experts Grace A. McComsey, MD, FIDSA, and Richard A. Elion, MD, how to identify people who may be candidates for pharmacologic weight interventions, and hear firsthand from patient advocates how unwanted weight gain impacts their daily life.

Topics covered include:

• The burden of unwanted weight gain among people living with HIV 
• Potential causes for unwanted weight gain
• Available pharmacologic agents for weight loss 
• Clinical trial data supporting pharmacologic agents for weight loss in people living with HIV
• Patient advocate perspectives

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify.

Link to full program: 
https://bit.ly/4cpeJ1I

Presenters:

Richard A. Elion, MD
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Grace A. McComsey, MD, FIDSA
Vice Dean for Clinical and Translational Research
Director, Clinical and Translational Science Institute (CTSI)
Principal Investigator, Clinical and Translational Science Collaborative (CTSC) of Northern Ohio
Gertrude Chandler Tucker Professor of Pediatrics and Medicine
Case Western Reserve University
Research Integrity Officer
Senior Faculty, Pediatric and Adult Infectious Diseases
University Hospitals Health System
Cleveland, Ohio

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, featuring audio from a local live workshop, experts Richard Colgan, MD, and Christopher Smith, MD, explore the burden of complicated urinary tract infection (cUTI) on patients and the healthcare system, highlight advances in the treatment of complicated UTIs, and examine approaches to empiric and definitive antibiotic therapy. Topics covered include:

• The Burden of cUTI and Antimicrobial Resistance
• Changes in IDSA Guidelines for cUTI
• Diagnosing cUTI
• Selection of Empiric and Definitive Therapy
• Novel Treatments for cUTI

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters: 

Richard Colgan, MD
Professor Emeritus
Department of Family and Community Medicine
University of Maryland School of Medicine
Baltimore, Maryland

Christopher Smith, MD
Infectious Disease Physician
Chase Brexton Healthcare
Clinical Assistant Professor
Shock Trauma Center, University of Maryland Medical Center
Baltimore, Maryland

Link to program page: 
https://bit.ly/3Q4TgDK

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“Good enough” is no longer good enough when caring for treatment-experienced people with HIV. Tune in to find out what’s new in management of multidrug-resistant HIV and dig into the latest data from CROI 2026. Topics covered include:

Real-world experiences with LEN in the United States and Europe for management of multidrug-resistant HIV

• Pharmacokinetic profiles of combined LA CAB + LEN
• Ibalizumab for multidrug-resistant HIV
• Long-term 7-year outcomes for heavily treatment–experienced people living with HIV and 4-class drug resistance

To download the accompanying slides, please visit the program page: 
https://bit.ly/4pEenZC

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Onyema Ogbuagu, MD, FACP, FIDSA
Professor of Medicine and Pharmacology
Director, Yale Antivirals and Vaccines Research Program
Yale School of Medicine
New Haven, Connecticut

Charlotte-Paige Rolle, MD, MPH
Director of Research Operations
Orlando Immunology Center
Adjunct Assistant Professor of Global Health
Emory University Rollins School of Public Health
Atlanta, Georgia

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune into this podcast, featuring audio from a live conference coverage webinar, to learn from global experts, Monica Gandhi, MD, MPH, and Jean-Michel Molina, MD, as they summarize and discuss the latest updates on HIV treatment and prevention from CROI 2026. Topics covered include:

• Emerging HIV treatments
• Advances in HIV prevention
• Investigational agents for HIV prevention
• Early-phase investigational HIV treatments

For more coverage of CROI 2026, and to follow along with the downloadable slides, visit the program page:
https://bit.ly/4bmS062

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Monica Gandhi, MD, MPH
Professor of Medicine and Associate Chief
Division of HIV, Infectious Diseases, and Global Medicine
Director, UCSF Center for AIDS Research (CFAR)
Director of HIV Special Program
"Ward 86" HIV Clinic
San Francisco General Hospital
San Francisco, California

Jean-Michel Molina, MD
Professor of Medicine
Saint-Louis and Lariboisire Hospitals
Université Paris Cité
Paris, France

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT), but there have been major advances in CMV management to date. In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV.

Topics include:

• Considerations for CMV management in HCT recipients
• New definitions of refractory and resistant CMV 
• Risk factors for refractory and resistant CMV infections
• Identifying drug-resistant CMV 
• Treatment options for refractory/resistant CMV

To view the full educational program and download the accompanying slides, visit our website:
https://bit.ly/4lfrDTT

Presenters:

Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID
Professor and Chair
G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases
President, The International Immunocompromised Host Society (ICHS)
Director, Clinical Virology Research
Department of ID/IC/EH
UT MD Anderson Cancer Center
Houston, Texas

Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include:

• Epidemiology of CMV among HCT recipients
• Direct and indirect effects of CMV after HCT
• Dynamics of risk factors for CMV infection 
• Strategies for prevention of CMV infection

To view the full educational program and download the accompanying slides, visit our website:
https://bit.ly/4lfrDTT

Presenters:

Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID
Professor and Chair
G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases
President, The International Immunocompromised Host Society (ICHS)
Director, Clinical Virology Research
Department of ID/IC/EH
UT MD Anderson Cancer Center
Houston, Texas

Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, experts Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH; Ruth Carrico, PhD, DNP, FNP-C, FAAN; and Dalilah Restrepo, MD, discuss improving shingles vaccine uptake. Topics covered include: 

• The Burden of Shingles
• Care Coordination Between Primary and Specialty Care
• Promoting Shingles Vaccine Series Completion
• Addressing Disparities in Shingles Vaccine Access and Uptake

Presenters:

Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH
Associate Professor of Clinical Pharmacy
University of California, San Diego
Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences
Division of the Black Diaspora and African American Studies
La Jolla, California

Ruth Carrico, PhD, DNP, FNP-C, FAAN
Senior Partner
Carrico & Ramirez PLLC
Professor, Adjunct
Division of Infectious Diseases
University of Louisville School of Medicine
Louisville, Kentucky

Dalilah Restrepo, MD
Infectious Diseases Specialist
University of California, Irvine
Los Alamitos Hospital
Orange County, California

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.

Topics covered include:

• Mechanisms of pruritus and fatigue in PBC
• Nonpharmacologic treatment options
• An overview of clinical trial data supporting second-line agents for symptom management:
• Bezafibrate
• Elafibranor
• Seladelpar
• Investigational agents:
• Volixibat
• Linerixibat
• Setanaxib

This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/44ZJ5os

Presenters:
Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, 
MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.

Topics covered include:

• Available agents for second-line treatment of PBC
• An overview of clinical trial data supporting second-line agents:
• Obeticholic acid (OCA)
• Bezafibrate
• Elafibranor
• Seladelpar

This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include:

• How and when to assess treatment response
• Risk factors in PBC
• Biochemical treatment response and fibrosis stage as predictors of transplant-free survival
• Dynamics of liver stiffness measurements and clinical outcomes in PBC
• The importance of bilirubin and alkaline phosphatase normalization

This episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.

Topics covered include: 

• Methods of Assessing PBC Disease Progression
• Newer Agents for Second-line Treatment of PBC
• Prioritizing Symptom Management and Quality of Life With PBC Treatment

Presenters:

Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine 
University of California Davis 
Sacramento, California

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Link to full program: 
https://bit.ly/43nHx6U

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice. 

Topics covered include:

• Treatment Goals
• Long-term Data With PPAR Agonists
• Investigational Therapies for Pruritus

Presenter: 

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To download the accompanying slides, visit the program page for this episode: 
https://bit.ly/4b2d6YD

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include:

• The Canadian PBC Society Survey: Comorbidities and Treatment Goals
• Defining and Achieving Goal-Driven Care for PBC
• Recent Advances in PBC Management
• Newer Agents for Second-line Treatment of PBC

Presenters:

Maria G. Morais, RN
PBC Transplant Patient
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

Link to full program:
https://bit.ly/44ySoL3

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen to this podcast featuring highlights from our expert roundtable discussion to learn about the most pressing issues in pediatric influenza vaccines, including current vaccine technologies, recent vaccine uptake and epidemiologic trends, and how to discuss the vast benefits of timely vaccination in pediatric patients with their parents and caregivers. Topics covered include:

• Groups at High Risk for Complications
• Guideline Recommendations for Influenza Vaccination
• Available Seasonal Flu Vaccine Formulations and Their Characteristics
• Practical Considerations for Selecting Pediatric Influenza Vaccines
• Uptake of Influenza Vaccines in Children: Reversing the Trends

Presenters:

Ravi Jhaveri, MD, FIDSA, FPIDS, FAAP
Division Head
Pediatric Infectious Diseases
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Professor of Pediatrics
Feinberg School of Medicine of Northwestern University
Pediatric Infectious Diseases Attending
Medical Director, International Adoptee Clinic
President, Lurie Medical/Dental Staff
Ann & Robert H. Lurie Children’s Hospital of Chicago
Chicago, Illinois

Jennifer M. Walsh, DNP, CPNP-PC, CNE
Certified Pediatric Nurse Practitioner, Primary Care
Assistant Professor
George Washington University
School of Nursing
Washington, DC

Link to full program: 
https://bit.ly/45UVzy6

Get access to all of our new episodes by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.

Topics covered include:

• Immunologic nonresponse
• Theories around soluble gp120 and antibody-dependent cellular cytotoxicity
• Latest data from BRIGHTE, RECOVER, and more
• Future Directions

Presenters:

Princy N. Kumar, MD, MACP, FRCP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Vice Dean for Student Affairs
Georgetown University School of Medicine
Washington, DC

Charlotte-Paige Rolle, MD, MPH
Director of Research Operations
Orlando Immunology Center
Adjunct Assistant Professor of Global Health
Emory University Rollins School of Public Health
Atlanta, Georgia

To download the accompanying slides, please visit the program page: 
https://bit.ly/4pEenZC

Get access to all of our new podcasts by subscribing on Apple Podcasts, YouTube Music, or Spotify!

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune into this podcast to revisit discussions led by global experts, Karine Lacombe, MD, PhD, and Chloe Orkin, MBChB, FRCP, MD, featuring the latest updates on HIV treatment and prevention from the 2025 IDWeek and EACS conferences.

Topics covered include:

• Real-world safety and efficacy of long-acting ART
• ART switch: preferences, treatment satisfaction, changes in weight and metabolic parameters, and HBV reactivation risk
• Investigational therapies
• Updates on long-acting PrEP: persistence, use in people with substance use disorder, and coadministration with gender-affirming hormone therapy
• HIV and STI screening with PrEP
• STI prevention 

To download the accompanying slides, visit the program page for this episode:
https://bit.ly/3MGvegM

Presenters:
Karine Lacombe, MD, PhD
Professor of Medicine
Sorbonne University
Head of Infectious Diseases Unit
St Antoine Hospital, AP-HP
Paris, France

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Get access to all of our new episodes by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, featuring audio from an expert roundtable video module, listen as 3 multidisciplinary faculty, Tracey Q. Davidoff, MD, FCUCM; Carina Marquez, MD, MPH; and Jeffrey D. Whitman, MD, MS, discuss the benefits of diagnosing respiratory syncytial virus (RSV) and optimal testing strategies. Topics covered include:

• The annual burden of RSV and the benefits of diagnosis
• Whom to test and what diagnostic techniques to use
• Logistical considerations for implementation
• Potential benefits of RSV testing

For the full video module and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/3MrXTpI

Presenters:
Tracey Q. Davidoff, MD, FCUCM
Attending Physician
Baycare Urgent Care
Assistant Professor, Family Medicine
Florida State University College of Medicine
Tallahassee, Florida

Carina Marquez, MD, MPH
Associate Professor of Medicine
Division of HIV, Infectious Diseases and Global Medicine
University of California, San Francisco
San Francisco, California

Jeffrey D. Whitman, MD, MS
Co-Director of Clinical Microbiology
Associate Professor
Department of Laboratory Medicine
University of California, San Francisco
San Francisco, California

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Every day, I hear patients share worries shaped by the growing wave of vaccine misinformation—questions that reveal just how overwhelming today’s “infodemic” has become. In this podcast, I explore what vaccine hesitancy really looks like and how pharmacists can use empathy, strong recommendations, and meaningful dialogue to help rebuild confidence in immunization.

Presenter:
Mary Barna Bridgeman, PharmD, BCPS, BCGP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Clinical Pharmacy Specialist
Robert Wood Johnson University Hospital-New Brunswick
New Brunswick, New Jersey

Link to full program:
https://bit.ly/4oHDWZq

Get access to all of our new episodes by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This episode focuses on hearing the voices of transgender people living with HIV and their advocates as they share what matters most to them when it comes to healthcare services and where HIV fits among those priorities. We also consider how these insights can assist healthcare professionals in configuring HIV care to better meet the needs of this key population. Topics addressed include:

• Overarching health and well-being priorities within the broader context of everyday life challenges 
• Personal experiences of suboptimal interactions with healthcare services, and their impact on health-seeking behaviors
• Key components of a transgender-welcoming healthcare environment 
• Principles of people-centered care including integrating HIV care with gender-affirming care
• Concerns regarding HIV management that HIV healthcare professionals should anticipate and address

Faculty: 

Torrey Burke
Patient Advocate
United States

Erika Castellanos
Executive Director
Global Action for Trans Equality
The Netherlands

Aryah Lester, IC/SME
Patient Advocate
United States

Tanya Laguing
President DIOSSA (Decent Image of South Signal Association)
Hub Manager (Lily By LoveYourself x DIOSSA)
Hub Manager (Orange By LoveYourself x DIOSSA)
Taguig City, Philippines
Paranaque City, Philippines
Las Pinas, Philippines

Link to full program:
https://bit.ly/4oLXa08

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include:

• CDC and US Preventive Services Task Force STI screening recommendations
• Whether or not laboratory-based STI tests contribute to increasing antibiotic resistance
• Role of point-of-care testing and strategies for implementation

Presenter:
Jeffrey D. Klausner, MD, MPH
Clinical Professor of Medicine
Population and Public Health Sciences Lead
Infectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) Initiative
Keck School of Medicine of the University of Southern California
Los Angeles, California

Link to full program:
https://bit.ly/4nS7rYE

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The crux of HIV care and prevention is quick and accurate diagnosis. Listen in to learn from Aniruddha (Anu) Hazra, MD, and Dr. Nancy S. Miller about the advantages and potential pitfalls of different HIV testing algorithms to find out which one is best suited for your practice.

Presenters:

Aniruddha (Anu) Hazra, MD
Associate Professor, Section of Infectious Diseases and Global Health
Medical Director, UCM Sexual Wellness Clinic
Director of STI Services, Chicago Center of HIV Elimination
Department of Medicine
University of Chicago
Chicago, Illinois

Nancy S. Miller, MD
Medical Director, Clinical Microbiology and Molecular Diagnostics
Clinical Professor, Department of Pathology and Laboratory Medicine
Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts

Link to full program:
https://bit.ly/4nS7rYE

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections (ABSSSIs). Their insightful discussion focuses on antibiotic developments that followed publication of the IDSA practice guidelines in 2014 and the challenges unique to ABSSSIs, including a lack of determined bacterial etiology for many cases. 

Presenters

Thomas P. Lodise, PharmD, PhD
Professor
Albany College of Pharmacy and Health Sciences
Infectious Diseases Clinical Pharmacy Specialist
Stratton VA Medical Center
Albany, New York

George Sakoulas, MD, FIDSA
Chief, Infectious Diseases
Sharp Rees-Stealy Medical Group
Adjunct Professor of Pediatrics
University of California San Diego School of Medicine
San Diego, California

Link to full program:
https://bit.ly/4oIKwzs

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include:

• Reasons to consider regimen optimization in setting of viral suppression
• Available switch regimens, including 2-drug regimens and long-acting ART
• Approaches to assess for resistance before starting long-acting cabotegravir plus rilpivirine 
• DHHS recommendations on proviral DNA genotyping
• ART optimization strategies for patients living with viral suppression and history of underlying resistance

Presenters:

Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington

Cristina Mussini, MD
Professor of Infectious Diseases
Chief of the Division of Infectious Diseases, Policlinico, Modena
University of Modena and Reggio Emilia
Modena, Italy 

Link to full program and accompanying slides: 
https://bit.ly/4pAI66g

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ryan K. Shields, PharmD, MS, in the third of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include:

• Mechanisms of resistance in S. maltophilia
• Current frontline therapies
• 2024 IDSA guidance for treatment

Presenter:

Ryan K. Shields, PharmD, MS 
Associate Professor of Medicine
Co-Director, Center for Innovative Antimicrobial Therapy
University of Pittsburgh
Co-Director, Antibiotic Management Program
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Link to full program and downloadable slides:
https://bit.ly/3JWaqRv

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Marin H. Kollef, MD in the first of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include

• Antimicrobial resistance mechanisms
• Diagnostic strategies for identifying resistance
• Antibiotic selection strategies
• Preferred and alternative antibiotics according to guideline recommendations

Presenter:

Marin H. Kollef, MD
Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine
Professor of Medicine
Division of Pulmonary & Critical Care Medicine
Director, Critical Care Research
Director, Respiratory Care Services
Washington University School of Medicine
St Louis, Missouri

Link to full program and downloadable slides:

CCO: 
https://bit.ly/4omLRLB

ProCE: 
https://bit.ly/4pA1Xm4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ryan K. Shields, PharmD, MS, in the second of three recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients.” Learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include:

• The diverse mechanisms of β-lactam resistance
• The effect of resistance mechanisms on susceptibility to antimicrobials 
• 2024 IDSA guidance for treatment
• Considerations for antibiotic selection
• The role of combination therapy

Presenter:

Ryan K. Shields, PharmD, MS 
Associate Professor of Medicine
Co-Director, Center for Innovative Antimicrobial Therapy
University of Pittsburgh
Co-Director, Antibiotic Management Program
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Link to full program and downloadable slides:

CCO: 
https://bit.ly/3LXzate

ProCE: 
https://bit.ly/3Mjao6G

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:

• Efficacy of switching to 2-drug oral ART: real-world evidence
• Real-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirine
• Patient selection to reduce risk of virologic failure with switch 
• Regimen-specific switch considerations

Presenters:

Dima Dandachi, MD, MPH, FIDSA, FACP
Associate Professor of Medicine
Division of Infectious Diseases
University of Missouri
Medical Director
HIV Treatment and Prevention Program, MUHC
Medical Director
Boone County Public Health and Human Services
Columbia, Missouri

Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Link to full program and accompanying slides:
https://bit.ly/3KPN0xb

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:

• Considerations for implementation
• Decision-making steps for implementation
• The role of antimicrobial stewardship programs in AST workflow

Presenter:

Michael P. Veve, PharmD, MPH
Clinical Associate Professor
Department of Pharmacy Practice
Eugene Applebaum College of Pharmacy and Health Sciences
Wayne State University
Clinical Pharmacy Specialist, Infectious Disease
Henry Ford Hospital
Detroit, Michigan

Link to full program and downloadable slides:
https://bit.ly/4inoXCx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:

• Typical patterns of intrinsic antibiotic susceptibility and resistance in Enterobacterales
• Mechanisms of resistance in gram-negative bacteria
• Genotypic rapid diagnostic tests for BSIs
• Resistance markers for earlier targeted therapy
• Rapid phenotypic antimicrobial susceptibility test platforms for blood cultures

Presenter:

Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP)
Medical and Public Health Microbiologist
Medical and Technical Director of Microbiology
AdventHealth
Orlando, Florida

Link to full program and downloadable slides:
https://bit.ly/4inoXCx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:

• The worldwide burden of sepsis and BSIs
• The ongoing threat of antimicrobial resistance
• US and global health disparities in sepsis, BSI, and antimicrobial resistance
• Barriers toward optimizing antibiotic use in BSIs

Presenter:

Jasmine R. Marcelin, MD, FACP, FIDSA
Associate Professor, Infectious Disease
Associate Medical Director, Antimicrobial Stewardship Program
Vice Chair for Belonging and Community Engagement, Department of Internal Medicine
Co-Director, Digital Innovation & Social Media Strategy, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, Nebraska

Link to full program and downloadable slides:
https://bit.ly/4inoXCx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:

• PrEP candidacy 
• Selection of individualized regimens
• Key barriers to PrEP use
• Strategies for overcoming key barriers to PrEP access
• Evolving state-based legislation on PrEP provision by pharmacists
• Models of pharmacy-managed PrEP
• Strategies for addressing inequities in PrEP care
• Comprehensive HIV prevention services

Presenters:

Tessa Rife-Pennington, PharmD, BCGP
Dr. Dawn K. Smith HIV Prevention Clinical Fellow
American Academy of HIV Medicine
Volunteer Assistant Clinical Professor
University of California, San Francisco, School of Pharmacy
San Francisco, California

Frank North, PharmD, MPA, DPLA, DASPL
Instructional Assistant Professor, Irma Lerma Rangel College of Pharmacy
Director of Learning in Practice
Office of Interprofessional Practice, Education and Research
Texas A&M University Health Science Center
Past President, National Pharmaceutical Association
College Station, Texas

Link to full program: 
https://bit.ly/49SLc0y

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include: 

• How to approach a patient with complex barriers to engagement in healthcare
• Resources for staying in care, such as wraparound services
• Setting SMART goals and formulating action plans with patients
• Deconstructing stigma and implementing a trauma-informed approach to care

Presenters:

Shellye Jones, MSW, LCSW
Clinical Supervisor
Charles R. Drew University, Drew CARES
Los Angeles, California

Lauren Harris Jackson
Street Medicine Patient Navigator
Healthcare in Action
Los Angeles, California

Link to full program: 
https://bit.ly/3Wh4Z1T

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include:

• International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral Suppression
• Considerations for switching to a 2-drug regimen or long-acting ART
• Methods for assessing patient satisfaction with their current ART regimen

Presenters:

Monica Gandhi, MD, MPH
Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
University of California, San Francisco (UCSF)
San Francisco, California

Luis Buzon Martin, MD
Division of Infectious Diseases
Hospital Universitario de Burgos
Burgos, Espana

Link to full program and accompanying slides: 
https://bit.ly/3KPN0xb

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure, and how he handles each scenario.

Presenter:

Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington

Link to full program: 
https://bit.ly/4nS7rYE

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual’s specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include:

• Individualizing Antiretroviral Regimens for Treatment-Experienced People With HIV
• Strategies to Improve Adherence and Addressing Barriers to Engagement in Care
• Person-Centered, Trauma-Informed Care
• Resistance Testing in the Setting of Virologic Failure
• Selection of ARVs With a Failing Regimen

Presenters:
Clíona Ní Cheallaigh, MB, MRCP, PhD
Consultant Physician
Inclusion Health Services
St James’s Hospital Dublin
Associate Professor
Department of Medicine
Trinity College Dublin
Dublin, Ireland

Link to full program:
https://bit.ly/4oiYxEx

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:

• Management for suspected drug-resistant CMV infection 
• Illustrative patient cases 
• Gene mutations in CMV 

Presenters:

Atul Humar, MD, FRCPC, FAST
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada

Camille Kotton, MD, FIDSA, FAST 
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts

Link to full program:
https://bit.ly/4lOa2kA

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:

• Direct and indirect effects of CMV infection
• Risk factors for resistant/refractory CMV
• Defining resistant/refractory CMV

Presenter:
Camille Kotton, MD, FIDSA, FAST 
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts

Link to full program:
http://bit.ly/4lOa2kA

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:

• Comparisons of available CMV antiviral therapies:
  • Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir
• Considerations for renal function monitoring with ganciclovir and valganciclovir
• A treatment algorithm for relapsed/refractory CMV
• The latest clinical trial data and guideline recommendations

Presenter:
Atul Humar, MD, FRCP (C) 
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada

Link to full program:
https://bit.ly/4lOa2kA

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include: 

• Risk factors and prevention of late-onset CMV disease
• Early detection of late CMV infection
• CMV cell-mediated immunity monitoring
• Primary and secondary prophylaxis

Presenters:         

Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
Division of Infectious Diseases
Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Link to full program:
https://bit.ly/41ejruC

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include: 

• CMV pathogenesis
• Direct and indirect effects of CMV infection 
• Overview of patient risk factors
• CMV risk based on serologic status

Presenters:         

Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
Division of Infectious Diseases
Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Link to full program:
https://bit.ly/41ejruC

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.